Analysts' Opinions Are Mixed on These Healthcare Stocks: Mainz Biomed B.V. (MYNZ) and Check-Cap (CHEK)
Analysts Have Conflicting Sentiments on These Healthcare Companies: Agile Therapeutics (AGRX), Check-Cap (CHEK) and Doximity (DOCS)
HC Wainwright & Co. Reiterates Buy on Check-Cap, Maintains $7 Price Target
Check-Cap (CHEK) Gets a Buy From H.C. Wainwright
HC Wainwright Adjusts Check-Cap's Price Target to $7 From $15, Keeps Buy Rating
HC Wainwright & Co. Reiterates Buy on Check-Cap, Lowers Price Target to $7
H.C. Wainwright Remains a Buy on Check-Cap (CHEK)
H.C. Wainwright Reaffirms Their Buy Rating on Check-Cap (CHEK)
Dawson James Reaffirms Their Hold Rating on Check-Cap (CHEK)
H.C. Wainwright Remains a Buy on Check-Cap (CHEK)
No Data